Touchstone
Last syncOct 31, 2026, 6:54 PM ET

HIMS

Hims & Hers Health, Inc. Health Care Services-Offices & Clinics of Doctors of Medicine Russell 3000
$27.68Close $14.52 – $45.4652-week range Nov 9, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 3 of 8 trend conditions
  • Lagging the market RS 24 · weaker than 76% of stocks over 12 months
  • Far from its high 39% below its 52-week high
  • Earnings shrinking EPS −325% year on year
  • Results soon Nov 9, 2026, in 8 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 10, 2026
Off 12-month high 39%
1wk down 0.1% price change
1mo down 7.1% price change
12-month return down 37% market up 11% · its own down 51%
F-score — — Not assessed
Altman Z″ 1.61 Moderate risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B — price / book
Earnings yield — EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 59% year on year
EPS growth down 325% latest quarter · -24 pts
Sales growth up 38% latest quarter · +34 pts
ROE up 25% return on equity
Free cash margin up 2% $57.4M FCF
D/E — long-term debt / equity
Net debt / EBITDA -1.4× net cash
Interest cover —EBIT / interest

Trade setup

ATR% 6.5% $1.80 a day · 2×ATR $24.08
RS 24 / 99 vs the universe
Trend 3 / 8 trend template
Relative volume 1.1× vs 50-day average
Up/down volume 1.03 50 sessions
Implied move — no option chain · report Nov 9, 2026
Trend template · 3 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: fails
  • 50-day average above the 150 and 200-day: passes
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: passes
  • Within 25% of the 52-week high: fails
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Gross margin narrowing Gross margin fell from 79.5% to 73.8%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 10, 2026
Results reaction Aug 10, 2026-3% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.3B +59% on FY2024
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $148.8M FY2021 · $271.9M FY2022 · $526.9M FY2023 · $872.0M FY2024 · $1.5B FY2025 · $2.3B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $128.4M +2% on FY2024
-$200M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$18.1M FY2021 · -$107.7M FY2022 · -$65.7M FY2023 · -$23.5M FY2024 · $126.0M FY2025 · $128.4M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $57.4M -71% on FY2024
-$50M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$2.5M FY2021 · -$34.4M FY2022 · -$33.7M FY2023 · $47.0M FY2024 · $198.3M FY2025 · $57.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 74%
  • Net 5%
  • Free cash 2%
-50% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 74% · Net -12% · Free cash -2% FY2021 · Gross 75% · Net -40% · Free cash -13% FY2022 · Gross 78% · Net -12% · Free cash -6% FY2023 · Gross 82% · Net -3% · Free cash 5% FY2024 · Gross 79% · Net 9% · Free cash 13% FY2025 · Gross 74% · Net 5% · Free cash 2%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $27.3M FY2021 · Cash $71.8M FY2022 · Cash $46.8M FY2023 · Cash $96.7M FY2024 · Cash $220.6M FY2025 · Cash $228.6M
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $148.8M $271.9M $526.9M $872.0M $1.5B $2.3B
Gross margin 74% 75% 78% 82% 79% 74%
Operating income -$15.1M -$115.0M -$68.7M -$29.5M $61.9M $105.6M
Net income -$18.1M -$107.7M -$65.7M -$23.5M $126.0M $128.4M
Net margin -12% -40% -12% -3% 9% 5%
Earnings per share -$0.51 -$0.58 -$0.32 -$0.11 $0.53 $0.50
Free cash flow -$2.5M -$34.4M -$33.7M $47.0M $198.3M $57.4M
Free cash margin -2% -13% -6% 5% 13% 2%
Cash $27.3M $71.8M $46.8M $96.7M $220.6M $228.6M
Shareholders' equity -$146.9M $334.6M $311.7M $344.0M $476.7M $540.9M

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 10, 2026 Quarterly ↗ Jun 30, 2026 41d
May 11, 2026 Quarterly ↗ Mar 31, 2026 41d
Feb 23, 2026 Annual ↗ Dec 31, 2025 54d
Nov 3, 2025 Quarterly ↗ Sep 30, 2025 34d
Aug 4, 2025 Quarterly ↗ Jun 30, 2025 35d
May 5, 2025 Quarterly ↗ Mar 31, 2025 35d
Feb 24, 2025 Annual ↗ Dec 31, 2024 55d
Nov 4, 2024 Quarterly ↗ Sep 30, 2024 35d
Aug 5, 2024 Quarterly ↗ Jun 30, 2024 36d
May 6, 2024 Quarterly ↗ Mar 31, 2024 36d
Feb 26, 2024 Annual ↗ Dec 31, 2023 57d
Nov 6, 2023 Quarterly ↗ Sep 30, 2023 37d

Current reports

FiledDisclosed
Oct 7, 2026 Director or officer change ↗
Aug 10, 2026 Results ↗
Jul 17, 2026 Director or officer change ↗
Jul 1, 2026 Material agreement · New obligation ↗
Jun 15, 2026 Shareholder vote ↗
Jun 2, 2026 Material agreement · New obligation · Other events ↗
May 21, 2026 Material agreement · New obligation · Unregistered share sale ↗
May 19, 2026 Other events ↗
May 11, 2026 Results ↗
Mar 11, 2026 Regulation FD ↗
Feb 23, 2026 Results ↗
Feb 19, 2026 Material agreement · Unregistered share sale · Regulation FD ↗